Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined …
SA McNeil, F Noya, M Dionne, G Predy, W Meekison… - Vaccine, 2007 - Elsevier
The annual contact for influenza vaccination provides an opportunity to ensure that adults
have received other recommended vaccines such as Tdap. Healthy 19–64 year-olds were …
have received other recommended vaccines such as Tdap. Healthy 19–64 year-olds were …
Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults
WM Weston, V Chandrashekar, LR Friedland… - Human …, 2009 - Taylor & Francis
Annual vaccination with trivalent influenza vaccine (TIV), and a single dose of tetanus toxoid-
reduced diphtheria toxoid-acellular pertussis (Tdap) vaccine, are both recommended for …
reduced diphtheria toxoid-acellular pertussis (Tdap) vaccine, are both recommended for …
An adolescent–adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less …
JM Langley, G Predy, R Guasparini, B Law… - Vaccine, 2007 - Elsevier
In Canada, the fifth dose of the routine childhood immunization schedule against diphtheria,
tetanus, pertussis and polio is given at 4–6 years of age. Up to 30% of children may have …
tetanus, pertussis and polio is given at 4–6 years of age. Up to 30% of children may have …
Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed …
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
recommended in Canada and the United States, a second dose of pertussis vaccine is not …
Immunogenicity and reactogenicity of a single dose of a diphtheria–tetanus–acellular pertussis component vaccine (DTaP) compared to a diphtheria–tetanus toxoid …
I Bartels, J Jüngert, S Lugauer, K Stehr, U Heininger - Vaccine, 2001 - Elsevier
We compared immunogenicity and reactogenicity of a single dose of DTaP vaccine
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …
(containing tetanus and diphtheria toxoids and four acellular pertussis antigens) with …
Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19–64 years of age
M Blatter, LR Friedland, WM Weston, P Li, B Howe - Vaccine, 2009 - Elsevier
PURPOSE: This study was conducted to assess the immunogenicity and safety of a tetanus
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine containing three …
Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®) A Review of its Properties and Use as a Single-Dose Booster …
PL McCormack - Drugs, 2012 - Springer
Reduced-antigen, combined diphtheria, tetanus and three-component acellular pertussis
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
vaccine (Tdap; Boostrix®) is indicated for booster vaccination against diphtheria, tetanus …
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) …
B Thierry-Carstensen, K Jordan, HH Uhlving, T Dalby… - Vaccine, 2012 - Elsevier
BACKGROUND: Increasing incidence of pertussis in adolescents and adults has stimulated
the development of safe and immunogenic acellular pertussis vaccines for booster …
the development of safe and immunogenic acellular pertussis vaccines for booster …
Immunogenicity of a combined diphtheria–tetanus–acellular pertussis vaccine in adults
P Van Damme, M Burgess - Vaccine, 2004 - Elsevier
Two clinical studies were undertaken to evaluate the immunogenicity of an adult-type dTpa
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …
booster vaccine (Boostrix™ by GlaxoSmithKline Biologicals). Blood samples taken prior to …
The safety of immunizing with tetanus–diphtheria–acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a …
EA Talbot, KH Brown, KB Kirkland, AL Baughman… - Vaccine, 2010 - Elsevier
BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …